About this document
Cysteine-Enhanced Tumor-Penetrating Peptide by shahidmalik004 is a document available to read on EtoBox.
The study investigates the modification of a tumor-targeting peptide, iRGD, by adding a cysteine residue to prolong its plasma half-life and enhance tumor penetration. This modification allows for covalent binding to plasma albumin, resulting in increased accumulation of the peptide in tumors and improved delivery of therapeutic agents. The findings suggest a simple strategy to enhance peptide pharmacokinetics and efficacy in cancer therapy.
- Author
- shahidmalik004
- Language
- EN